Interest Expense of Telomir Pharmaceuticals, Inc. from 31 Dec 2023 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Telomir Pharmaceuticals, Inc. quarterly and annual Interest Expense in USD history and change rate from 31 Dec 2023 to 31 Mar 2024.
  • Telomir Pharmaceuticals, Inc. Interest Expense for the quarter ending 31 Mar 2024 was $4,338,543.
Source SEC data
View on sec.gov
Interest Expense, Quarterly (USD)
Interest Expense, Annual (USD)

Telomir Pharmaceuticals, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $4,338,543 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024 2024 Q1

Telomir Pharmaceuticals, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,643,049 01 Jan 2023 31 Dec 2023 10-K 29 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.